| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.0018 | 0.9 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |